Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biote Corp. - Class A common stock (NQ:BTMD)

3.450 +0.020 (+0.59%)
Streaming Delayed Price Updated: 12:42 PM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biote Corp. - Class A common stock

< Previous 1 2 3 4 Next >
Biote Names Robert Peterson as Chief Financial Officer
From biote Corp.
Via Business Wire
Biote Reports Third Quarter 2023 Financial Results
From Biote
Via Business Wire
Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Biote Reports Second Quarter 2023 Financial Results
From Biote
Via Business Wire
Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division
From biote Corp.
Via Business Wire
InvestorNewsBreaks – Biote Corp. (NASDAQ: BTMD) Closes $31M Underwritten Public Offering
Via Investor Brand Network
Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
From Biote
Via Business Wire
Biote Announces Pricing of Secondary Offering of Common Stock
From biote Corp
Via Business Wire
Biote to Participate at Upcoming Investor Conferences
From biote Corp.
Via Business Wire
Biote Appoints Mary J. Puncochar as Chief Commercial Officer
From biote Corp.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Biote Reports First Quarter 2023 Financial Results
From Biote
Via Business Wire
Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
From Biote
Via Business Wire
Biote Schedules First Quarter 2023 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
Biote Names John Denne as General Manager, Men’s Health Division
From Biote
Via Business Wire
Biote Reports Fourth Quarter and Full Year 2022 Financial Results
From Biote
Via Business Wire
Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report
From Biote
Via Business Wire
Biote to Present at 35th Annual Roth Conference
From biote Corp.
Via Business Wire
Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call
From Biote Corp.
Via Business Wire
Over $4 Million Bet On Werewolf Therapeutics? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
Biote Announces Closing of Secondary Offering of 8,500,000 Shares of Common Stock Including Full Exercise of the Underwriters’ Over-Allotment Option
From biote Corp.
Via Business Wire
Biote Announces Pricing of Secondary Offering of Common Stock
From biote Corp
Via Business Wire
Biote to Present at Jefferies London Healthcare Conference
From biote Corp.
Via Business Wire
Biote Reports Third Quarter Financial Results
From Biote
Via Business Wire
Biote Appoints Debby Morris to Board of Directors
From biote Corp.
Via Business Wire
Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.